Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer’s disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer’s disease
Authors
Keywords
-
Journal
MOLECULAR DIVERSITY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-30
DOI
10.1007/s11030-021-10282-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Challenges in Alzheimer Disease Drug Discovery and Development: The Role of Modeling, Simulation and Open Data
- (2020) Daniela J Conrado et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer’s disease
- (2020) Vinay Kumar et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Synthesis, In Silico and In Vitro Evaluation of Some Flavone Derivatives for Acetylcholinesterase and BACE-1 Inhibitory Activity
- (2020) Thai-Son Tran et al. MOLECULES
- 3D QSAR studies on amphiphilic indoles for antimycobacterial activity
- (2020) Aparna Bahuguna et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease
- (2019) Piyoosh Sharma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
- (2019) Xin Yang et al. CHEMICAL REVIEWS
- QSAR Classification Models for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer’s Disease
- (2019) Ignacio Ponzoni et al. Scientific Reports
- Novel Molecular Hybrids of N-Benzylpiperidine and 1,3,4-Oxadiazole as Multitargeted Therapeutics to Treat Alzheimer’s Disease
- (2019) Piyoosh Sharma et al. ACS Chemical Neuroscience
- Ageing as a risk factor for neurodegenerative disease
- (2019) Yujun Hou et al. Nature Reviews Neurology
- Have there been improvements in Alzheimer’s disease drug discovery over the past 5 years?
- (2018) Ramón Cacabelos Expert Opinion on Drug Discovery
- Multiple e-Pharmacophore modeling to identify a single molecule that could target both streptomycin and paromomycin binding sites for 30S ribosomal subunit inhibition
- (2018) Anju C.P. et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Machine Learning-based Virtual Screening and Its Applications to Alzheimer’s Drug Discovery: A Review
- (2018) Kristy A. Carpenter et al. CURRENT PHARMACEUTICAL DESIGN
- 2D-SAR and 3D-QSAR analyses for acetylcholinesterase inhibitors
- (2017) Bing Niu et al. MOLECULAR DIVERSITY
- Drug treatments in Alzheimers disease
- (2016) R. Briggs et al. CLINICAL MEDICINE
- Machine-learning approaches in drug discovery: methods and applications
- (2015) Antonio Lavecchia DRUG DISCOVERY TODAY
- The rm2 metrics and regression through origin approach: Reliable and useful validation tools for predictive QSAR models (Commentary on ‘Is regression through origin useful in external validation of QSAR models?’)
- (2014) Kunal Roy et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Benefits of statistical molecular design, covariance analysis, and reference models in QSAR: a case study on acetylcholinesterase
- (2014) C. David Andersson et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- QSAR Modeling: Where Have You Been? Where Are You Going To?
- (2013) Artem Cherkasov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Electrotopological State Atom (E-State) Index in Drug Design, QSAR, Property Prediction and Toxicity Assessment
- (2012) Kunal Roy et al. Current Computer-Aided Drug Design
- Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands
- (2012) Jonah Cheung et al. JOURNAL OF MEDICINAL CHEMISTRY
- Searching for the Multi-Target-Directed Ligands against Alzheimer’s disease: Discovery of quinoxaline-based hybrid compounds with AChE, H3R and BACE 1 inhibitory activities
- (2011) Wenhai Huang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of dual binding site acetylcholinesterase inhibitors identified by pharmacophore modeling and sequential virtual screening techniques
- (2011) Shikhar Gupta et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Molecular Docking Guided Comparative GFA, G/PLS, SVM and ANN Models of Structurally Diverse Dual Binding Site Acetylcholinesterase Inhibitors
- (2011) Shikhar Gupta et al. Molecular Informatics
- Acetylcholinesterase: From 3D structure to function
- (2010) Hay Dvir et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Molecular modelling and QSAR analysis of some structurally diverse N-type calcium channel blockers
- (2009) Jignesh Mungalpara et al. JOURNAL OF MOLECULAR MODELING
- Comparative molecular field analysis and comparative molecular similarity indices analysis of hydroxyethylamine derivatives as selective human BACE-1 inhibitor
- (2009) Ashish Pandey et al. MOLECULAR DIVERSITY
- An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis
- (2008) Kuldeep K. Roy et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- 3D-QSAR CoMFA analysis of C5 substituted pyrrolotriazines as HER2 (ErbB2) inhibitors
- (2007) Mahendra Awale et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now